Which medication can lead to an increase in blood clots and is often reserved for specific cases in HRT?

• A. Progesterone
• B. Conjugated estrogens
• C. Levonorgestrel
• D. Desogestrel

Answer: (B)

Conjugated estrogens are associated with an increased risk of blood clots, particularly in women who may already have risk factors for thrombosis. In hormone replacement therapy (HRT), estrogens are utilized to alleviate menopausal symptoms, but they also have implications for the coagulation system that can lead to thromboembolic events.

Due to the potential for clot formation, conjugated estrogens are often reserved for specific cases where the benefits outweigh the risks. This is particularly true for women who are postmenopausal and may also present with additional risk factors such as obesity, a history of thromboembolism, or smoking.

When managed correctly, conjugated estrogens can provide significant relief from menopausal symptoms while being cognizant of their thrombogenic potential. Therefore, it's critical to evaluate each patient's individual risk factors when considering the introduction of conjugated estrogens into their treatment regimen.